<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with a 17-month history of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts that evolved into <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>), which was treated with transfusions and erythropoietin, developed abdominal and inguinal <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Biopsies of the abdominal nodes revealed virtual obliteration of the architecture by myeloid blasts admixed with maturing granulocytic, erythroid, and megakaryocytic precursors </plain></SENT>
<SENT sid="2" pm="."><plain>The lymph node findings appeared to represent extramedullary dyshematopoiesis undergoing a tissue phase blast transformation </plain></SENT>
<SENT sid="3" pm="."><plain>Four months later, the patient developed rising peripheral blast counts consistent with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Although the development of granulocytic <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (also called <z:e sem="disease" ids="C0152276" disease_type="Neoplastic Process" abbrv="">extramedullary myeloid cell tumor</z:e>) is well known to occur in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, to our knowledge this is the first description of an <z:e sem="disease" ids="C0152276" disease_type="Neoplastic Process" abbrv="">extramedullary myeloid cell tumor</z:e> associated with trilineage differentiation </plain></SENT>
</text></document>